Top compounds associated with response to LGALS9C


Feature Type Standardized
Nominal ANOVA
mRNA nintedanib CTRPv2 pan-cancer AAC -0.049 0.2
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.047 0.2
mRNA HBX-41108 CTRPv2 pan-cancer AAC -0.055 0.2
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.048 0.2
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA pluripotin CTRPv2 pan-cancer AAC 0.046 0.2
mRNA CD-1530 CTRPv2 pan-cancer AAC 0.05 0.2
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.046 0.2
mRNA BRD-K48334597 CTRPv2 pan-cancer AAC -0.092 0.2
mRNA OSI-930 CTRPv2 pan-cancer AAC -0.048 0.2
Download CSV